Results 31 to 40 of about 430 (135)

Correction to: The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma. [PDF]

Am J Clin Dermatol, 2022
BACKGROUND: Chlormethine/mechlorethamine gel is a skin-directed therapy for patients with mycosis fungoides cutaneous T-cell lymphoma. Currently, real-world data on chlormethine gel are lacking.
Kim EJ, Guitart J, Querfeld C, Girardi M, Musiek A, Akilov OE, Angello JT, Bailey WL, Geskin LJ.   +8 more
europepmc   +2 more sources

Methotrexate in mycosis fungoides revisited. [PDF]

J Eur Acad Dermatol Venereol
Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 8, Page 1374-1375, August 2025.
Dummer R, Suter A.
europepmc   +2 more sources

Mycosis fungoides and Sézary syndrome. [PDF]

Br J Haematol
Summary Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common cutaneous T‐cell lymphomas, arising from mature CD4+ memory T cells. Diagnosis is complex and relies on clinicopathological correlation, immunophenotyping and molecular clonality testing, while management is stage‐adapted, with potentially curative outcomes achievable only in ...
Martins F, Calvão J.
europepmc   +2 more sources

Metal–Metalloid Modified C36 Fullerene: A Dual Role in Drug Delivery and Sensing for Anticancer Chlormethine Explored through DFT and MD Simulations [PDF]

ACS Omega
Sourav Kanti Jana, Namrata A. Tukadiya, Adisak Boonchun, Prafulla K. Jha   +3 more
doaj   +2 more sources

First-principles study of the adsorption of chlormethine anticancer drug on C24, B12N12 and B12C6N6 nanocages

Computational and Theoretical Chemistry, 2021
Md. Abul Hossain, Md. Mehade Hasan, Siraj Ud Daula Shamim, Farid Ahmed, Md. Rakib Hossain, Tahmina Ferdous   +5 more
core   +2 more sources

Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience. [PDF]

Dermatol Ther (Heidelb), 2021
Geskin LJ, Bagot M, Hodak E, Kim EJ.
europepmc   +2 more sources

Publisher Correction to: Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings. [PDF]

Adv Ther, 2023
A plain language summary was retrospectively added to this ...
Wehkamp U, Ardigò M, Papadavid E, Querfeld C, Nikbakht N.   +4 more
europepmc   +2 more sources

Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study. [PDF]

Dermatol Ther (Heidelb), 2022
INTRODUCTION: Chlormethine (CL) gel is a skin-directed therapy approved for treatment of stage IA/IB mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) in the USA.
Querfeld C, Nelson WW, Gor D, Pashos CL, Doan QV, Turini M, Angello JT, Geskin LJ.   +7 more
europepmc   +2 more sources

Expert Opinions and Clinical Experiences With Chlormethine Gel as Maintenance Treatment for Patients With Mycosis Fungoides [PDF]

, 2023
Maintenance treatment can be recommended for patients with mycosis fungoides (MF) whose disease responds to primary treatment. While positive outcomes have been observed in small studies with maintenance therapy, there is a lack of practical guidelines ...
Bagot, Martine, Papadavid, Evangelia, Hodak, Emmilia, Nikbakht, Neda, Querfeld, Christiane, Ardigò, Marco, Wehkamp, Ulrike, Geskin, Larisa   +7 more
core   +1 more source

Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis Fungoides.

Dermatology, 2022
Mycosis fungoides (MF) is the most common form of cutaneous T-cell lymphoma. Patients can be treated using chlormethine gel, a skin-directed therapy developed and approved for MF.
Querfeld C, Scarisbrick JJ, Assaf C, Guenova E, Bagot M, Ortiz-Romero PL, Quaglino P, Bonizzoni E, Hodak E.   +8 more
europepmc   +2 more sources